Northwestern Mutual Wealth Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73K Buy
+74
New +$1.61K ﹤0.01% 3639
2024
Q3
Sell
-1,300
Closed -$26.7K 3825
2024
Q2
$26.7K Buy
+1,300
New +$27.2K ﹤0.01% 2307
2024
Q1
Sell
-50
Closed -$1.08K 3789
2023
Q4
$1.08K Buy
+50
New +$769 ﹤0.01% 3162

Other funds holding SNDX

Northwestern Mutual Wealth Management's SNDX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Syndax Pharmaceuticals (SNDX) in Q1 2026: 74 shares worth $1.73K. The stake represents ﹤0.01% of the portfolio and ranks #3639 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in SNDX as recently as Q2 2024.

Northwestern Mutual Wealth Management first reported a position in SNDX in Q4 2023 and has held it in 3 quarters since. The position peaked at $26.7K in Q2 2024. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Northwestern Mutual Wealth Management held 74 shares of Syndax Pharmaceuticals worth $1.73K as of Q1 2026.
  • Syndax Pharmaceuticals was a new Northwestern Mutual Wealth Management position in Q1 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3639 holding.
  • Northwestern Mutual Wealth Management first reported a position in Syndax Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
  • Northwestern Mutual Wealth Management's Syndax Pharmaceuticals position peaked at $26.7K in Q2 2024.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.